Richter Transformation clinical trials at UCSF
1 research study open to eligible people
Richter transformation is when a type of blood cancer changes into a more aggressive form. UCSF is studying NX-1607 to see how safe it is and how well it works against cancer. This trial is for adults with advanced stages of cancer.
Showing trials for
NX-1607 in Adults With Advanced Malignancies
open to eligible people ages 18 years and up
This is a first-in-human Phase 1a/1b multicenter, open-label oncology study designed to evaluate the safety and anti-cancer activity of NX-1607 in patients with advanced malignancies.
San Francisco, California and other locations
Last updated: